Boston Scientific Markets Four-Series USD Senior Notes to Fund $14.5B Penumbra Deal
BSX is trading near its 52-week low of $39.57 (9.6% above the low).
Summary
Boston Scientific is marketing four series of senior unsecured notes to help fund the cash portion of its roughly $14.5 billion Penumbra acquisition, with a 101% special mandatory redemption if the deal fails to close. Pricing, size and maturities are not yet set.
Key Events · Financing and Capital Events · BSX
-
Four-Series Senior Notes Offered
Preliminary prospectus supplement covers four series of senior unsecured notes; principal amounts, coupons and maturities are left blank pending pricing.
-
Proceeds Fund Penumbra Cash Consideration
Net proceeds, together with the concurrent euro notes offering, short-term borrowings and cash on hand, will finance the cash consideration for the roughly $14.5 billion Penumbra acquisition and related fees.
-
101% Special Mandatory Redemption
If the Penumbra deal is not completed by the later of January 14, 2027 (extendable to no later than January 14, 2028) or five business days after a later agreed Outside Date, or the company abandons the deal, each series must be redeemed at 101% of principal plus accrued interest.
-
No Escrow, Unsecured Ranking
Offering proceeds are not escrowed and no lien secures the notes; they rank equally with roughly $11,952 million of existing unsecured debt and are structurally junior to $141 million of subsidiary borrowings as of September 30, 2026.
Analysis · BSX · Industrial Applications And Services
Boston Scientific is selling four series of senior unsecured notes, with proceeds earmarked for the cash portion of its roughly $14.5 billion Penumbra acquisition, alongside a parallel euro notes sale by its Dutch finance subsidiary. The structure protects bondholders rather than shareholders: if the deal does not close by the outside date, the notes must be redeemed at 101% of principal, and the cash is not escrowed in the meantime. For equity holders the read-through is leverage, not dilution — the company already carried about $11,952 million of unsecured debt and no secured debt at September 30, 2026, so this adds to an already substantial debt load just as the August cyberattack has forced guidance cuts. Final size, coupons and maturities are blank in this preliminary supplement, so the actual cost of funding is not yet known.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BSX was trading at $43.36 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $63.3B. The 52-week trading range was $39.57 to $101.91. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.